Article
Therapeutic Target Identification in Pancreatic Ductal Adenocarcinoma: A Comprehensive In-Silico Study employing WGCNA and Trader
2023-03-01
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is recognized as a highly aggressive fatal disease accounting for more than 90% of all pancreatic malignancies. Considering the limited effective treatment options and its low survival rate, studying PDAC's underlying mechanisms is of utmost importance. The present study focused on investigating PDAC expression data using WGCNA and Trader algorithms to shed light on the unde...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e785b9d6-053e-5c54-9ab3-72e1d63ee25d
- DOI
- 10.21203/rs.3.rs-2627227/v1
